[Effect of macrolide therapy on microbes in nasal cavity and larynx of patients with chronic paranasal sinusitis].
Hashiba
M
M
Kondo
K
K
Hamashima
A
A
Koseki
A
A
Miyamoto
N
N
Murakami
S
S
Suzuki
Y
Y
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002176:Candida albicans / Q000302:isolation & purification; D017291:Clarithromycin / Q000008:administration & dosage*; D006801:Humans; D007830:Larynx / Q000382:microbiology*; D009296:Nasal Cavity / Q000382:microbiology*; D001443:Prevotella melaninogenica / Q000302:isolation & purification; D012852:Sinusitis / Q000188:drug therapy* / Q000382:microbiology*; D013210:Staphylococcus / Q000302:isolation & purification*; D013291:Streptococcus / Q000302:isolation & purification*; D013997:Time Factors
D000900:Anti-Bacterial Agents; D017291:Clarithromycin